期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 62, 期 2, 页码 199-204出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2008.06.013
关键词
tuberculosis; mutation; drug resistance
Of 142 pulmonary tuberculosis patients, 76 were considered high risk for the development of resistance, and 24 were confirmed as resistant strain carriers. Resistant isoniazid strains presented a high frequency of katG and ahpC mutations (90%) correlated with an MIC >4 mu 2/mL (94%). inh.4 mutations were not seen. rpoB mutations were identified in 78.6% of rifampicin-resistant strains, usually in codon 531 (72.7%), and 75% had an MIC >16 mu h/mL. katG and rpoB mutations recognized 88.2% of multidrug-resistant strains and proved more efficient than the katG and rpoB mutations alone. Seventy percent of resistant pyrazinamide strains had pncA mutations between genes 136 and 188. 62.5% of them with an MIC >900 mu g/mL. Pyrazinamidase Inactivity was not an efficient resistance marker because 60% of pncA Mutated strains maintained enzymatic activity despite displaying good correlation with high resistance levels. Resistant ethambutol strains had embB mutations in codon 306, with MIC >16 mu g/mL. (C) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据